How to Use Enzyme in React

Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn

Novo Nordisk will now run a Phase III trial for Omeros' former lead asset, zaltenibart in rare blood disorder, PNH.

一部の結果でアクセス不可の可能性があるため、非表示になっています。